Sector
PharmaceuticalsOpen
₹347.25Prev. Close
₹347.3Turnover(Lac.)
₹608.12Day's High
₹349.05Day's Low
₹342.852 Week's High
₹464.7552 Week's Low
₹309.15Book Value
₹103.69Face Value
₹2Mkt Cap (₹ Cr.)
4,259.42P/E
46.87EPS
7.37Divi. Yield
0.414 Feb 2025
12:00 AM
Dividend
Dividend Amount: 0.6
Record Date: 08 Feb, 2025
6 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
22 Aug 2024
12:00 AM
AGM
Announcement Date: 22 Aug, 2024
22 Aug 2024
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 24.66 | 24.66 | 24.66 | 24.66 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,162.93 | 1,108.83 | 1,043.35 | 908.76 |
Net Worth | 1,187.59 | 1,133.49 | 1,068.01 | 933.42 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 1,720.43 | 1,507.26 | 1,296.09 | 1,013.93 |
yoy growth (%) | 14.14 | 16.29 | 27.82 | 9.53 |
Raw materials | -908.37 | -776.32 | -698.97 | -509.37 |
As % of sales | 52.79 | 51.5 | 53.92 | 50.23 |
Employee costs | -164.31 | -156.56 | -128.05 | -116.69 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | 206.42 | 141.98 | 111.49 | 83.22 |
Depreciation | -85.24 | -82.46 | -85.59 | -69.14 |
Tax paid | -73.28 | -42.14 | -34.26 | -12.54 |
Working capital | 48.62 | 51.62 | 54.17 | 112.99 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 14.14 | 16.29 | 27.82 | 9.53 |
Op profit growth | 18.2 | 12.99 | 22.58 | 8.99 |
EBIT growth | 24.8 | 21.03 | 22.14 | 13.85 |
Net profit growth | 57.68 | 9.33 | 9.27 | 71.04 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 1,843.5 | 1,768.7 | 2,004.7 | 1,926.03 | 1,707.06 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,843.5 | 1,768.7 | 2,004.7 | 1,926.03 | 1,707.06 |
Other Operating Income | 16.3 | 15.9 | 18.33 | 16.69 | 13.38 |
Other Income | 5 | 2.5 | 5.41 | 4.89 | 4.98 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,679.7 | 94.05 | 4,02,788.36 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,876 | 82.52 | 1,82,282.67 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,508.7 | 25.32 | 1,21,846.76 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,334.1 | 59.26 | 1,12,908.79 | 474 | 0.96 | 2,385 | 224.33 |
Dr Reddys Laboratories Ltd DRREDDY | 1,291.3 | 20.06 | 1,07,932.29 | 1,200.7 | 0.62 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Chairman
Jai Hiremath
Vice Chairman & M.D.
Sameer Hiremath
Non-Exec & Non-Independent Dir
Sugandha Hiremath
Non-Exec & Non-Independent Dir
Amit B Kalyani
Non-Exec. & Independent Dir.
Shivani Bhasin Sachdeva
Company Sec. & Compli. Officer
Rajasekhar Reddy
Independent Director
Shrikrishna K. Adivarekar
Independent Director
Berjis Minoo Desai
Independent Director
V R Kaundinya
Independent Director
Ravi Brijmohan Kapoor
Independent Director
Ranjana Shivanand Salgaocar
Whole Time Director
Sarangan Suresh
717/718 Maker Chamber V,
7th Floor Nariman Point,
Maharashtra - 400021
Tel: 91-022-3926 7100/62770477
Website: http://www.hikal.com
Email: info@hikal.com
21 Shakil Niwas,
Mahakali Caves Road, Andheri (E),
Mumbai - 400 093
Tel: 91-22-28262920
Website: www.unisec.in
Email: info@unisec.in
Summary
Hikal Limited, incorporated on July 8, 1988, has emerged as one of the preferred partners for global companies in segments such as pharmaceuticals, crop protection, animal health, biocides, and specia...
Read More
Reports by Hikal Ltd
What is the Hikal Ltd share price today?
What is the Market Cap of Hikal Ltd?
What is the PE and PB ratio of Hikal Ltd?
What is the 52 Week High and Low of Hikal Ltd?
What is the CAGR of Hikal Ltd?
What is the shareholding pattern of Hikal Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.